Aspirin use and survival after coronary bypass surgery

This publication has 27 references indexed in Scilit:

• Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a Veterans Administration Cooperative Study.
  Circulation, 1989
• TRIAL OF LOW-DOSE ASPIRIN PLUS DIPYRIDAMOLE VERSUS ANTICOAGULANTS FOR PREVENTION OF AORTOCORONARY VEIN GRAFT OCCLUSION
  The Lancet, 1989
• Prevention of aortocoronary vein-graft attrition with low-dose aspirin and triflusal, both associated with dipyridamole: a randomized, double-blind, placebo-controlled trial
  European Heart Journal, 1989
• Long term clinical outcome of coronary surgery and assessment of the benefit obtained with postoperative aspirin and dipyridamole.
  Heart, 1988
• Failure of combined acetylsalicylic acid and dipyridamole to prevent occlusion of aortocoronary venous bypass graft
  Scandinavian Journal of Thoracic and Cardiovascular Surgery, 1987
• Improved Patency of the Aortocoronary Bypass by Antithrombotic Drugs
  The Annals of Thoracic Surgery, 1986
• Acetylsalicylic acid and dipyridamole improve the early patency of aorta-coronary bypass grafts
  The Journal of Thoracic and Cardiovascular Surgery, 1985
• Improved graft patency in patients treated with platelet-inhibiting therapy after coronary bypass surgery.
  Circulation, 1985
• Randomised placebo controlled trial of aspirin and dipyridamole in the prevention of coronary vein graft occlusion.
  Heart, 1985
• Low‐dose acetylsalicylic acid (100 mg/day) after aortocoronary bypass surgery: a placebo‐controlled trial.
  British Journal of Clinical Pharmacology, 1984